These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29301855)

  • 21. CRISPR-Cas systems: Challenges and future prospects.
    Gohil N; Bhattacharjee G; Lam NL; Perli SD; Singh V
    Prog Mol Biol Transl Sci; 2021; 180():141-151. PubMed ID: 33934835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome Editing in Translational Medicine: An Inventory.
    Dobner J; Ramachandran H; Rossi A
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):241. PubMed ID: 36042173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of genome editing technologies to the study and treatment of hematological disease.
    Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
    Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
    Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Gene Editing with CRISPR: A Laboratory Medicine Perspective.
    Hahn E; Hiemenz M
    Clin Lab Med; 2020 Jun; 40(2):205-219. PubMed ID: 32439069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals.
    Wani AK; Akhtar N; Singh R; Prakash A; Raza SHA; Cavalu S; Chopra C; Madkour M; Elolimy A; Hashem NM
    Vet Res Commun; 2023 Jan; 47(1):1-16. PubMed ID: 35781172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene editing tools: state-of-the-art and the road ahead for the model and non-model fishes.
    Barman HK; Rasal KD; Chakrapani V; Ninawe AS; Vengayil DT; Asrafuzzaman S; Sundaray JK; Jayasankar P
    Transgenic Res; 2017 Oct; 26(5):577-589. PubMed ID: 28681201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
    Kawahara A; Hisano Y; Ota S; Taimatsu K
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR/Cas9 Genome Editing Tool: A Promising Tool for Therapeutic Applications on Respiratory Diseases.
    Shaikh SB; Bhandary YP
    Curr Gene Ther; 2020; 20(5):333-346. PubMed ID: 33045965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A beginner's guide to gene editing.
    Harrison PT; Hart S
    Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders.
    March OP; Reichelt J; Koller U
    Exp Physiol; 2018 Apr; 103(4):449-455. PubMed ID: 28271571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of CRISPR-Cas systems in neuroscience.
    Bonnerjee D; Bagh S
    Prog Mol Biol Transl Sci; 2021; 178():231-264. PubMed ID: 33685599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Single-Molecule View of Genome Editing Proteins: Biophysical Mechanisms for TALEs and CRISPR/Cas9.
    Cuculis L; Schroeder CM
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():577-597. PubMed ID: 28489428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A history of genome editing in mammals.
    Fernández A; Josa S; Montoliu L
    Mamm Genome; 2017 Aug; 28(7-8):237-246. PubMed ID: 28589393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome editing comes of age.
    Kim JS
    Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases.
    Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
    Neurochem Int; 2018 Jan; 112():187-196. PubMed ID: 28732771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus.
    Gutierrez-Guerrero A; Sanchez-Hernandez S; Galvani G; Pinedo-Gomez J; Martin-Guerra R; Sanchez-Gilabert A; Aguilar-González A; Cobo M; Gregory P; Holmes M; Benabdellah K; Martin F
    Hum Gene Ther; 2018 Mar; 29(3):366-380. PubMed ID: 28922955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of Genome Editing Mutations in Cereal Crops.
    Zhu C; Bortesi L; Baysal C; Twyman RM; Fischer R; Capell T; Schillberg S; Christou P
    Trends Plant Sci; 2017 Jan; 22(1):38-52. PubMed ID: 27645899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects.
    Singh K; Bhushan B; Kumar S; Singh S; Macadangdang RR; Pandey E; Varma AK; Kumar S
    Curr Gene Ther; 2024; 24(5):377-394. PubMed ID: 38258771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.